{"nct_id":"NCT02621931","title":"Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2016-03-22","start_date_type":"ACTUAL","primary_completion_date":"2017-04-11","primary_completion_date_type":"ACTUAL","completion_date":"2017-04-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}